Position in RZLT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,100,000
+$1,380,000 QoQ
Shares Held
2,000,000
0.0% QoQ
Ownership
2.08%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integral Health Asset Management, LLC holds $1,255,592,830 across 56 Biotechnology names. RZLT ranks #40 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,500,000 | $245,280,000 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $145,875,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $105,456,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,000 | $65,674,400 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,600,000 | $64,368,000 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $55,400,000 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
600,000 | $52,182,000 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
1,600,000 | $50,400,000 |
All Filings in RZLT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,100,000 | 2,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,720,000 | 2,000,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,800,000 | 2,000,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,028,000 | 1,800,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,450,000 | 500,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,450,000 | 500,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,212,500 | 250,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||